Experimental drug ALMB-0166 tested in spinal cord injury patients
Disease control
Completed
This early-stage trial tested a single dose of an experimental drug called ALMB-0166 in 24 people with acute spinal cord injury. The main goal was to check safety and how the drug moves through the body. Participants had moderate to severe injuries and were scheduled for surgery …
Phase: PHASE1 • Sponsor: AlaMab Therapeutics (Shanghai) Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC